Sirio Pharma, a leading global nutraceutical contract development and manufacturing organisation (CDMO), has partnered with Vitamin Angels, a global public health nonprofit organisation dedicated to improving nutrition and health outcomes for the most nutritionally vulnerable groups — pregnant women, infants and children — by delivering evidence-based nutrition interventions.
As part of the partnership, Sirio has committed to an annual donation to help Vitamin Angels expand access to essential nutrition in underserved communities both in the US and around the world.
Operating in more than 65 countries, Vitamin Angels collaborates with local organisations to deliver nutrition programmes that address malnutrition.
Sirio’s contribution will help to support these initiatives and the organisation’s mission to improve maternal and child health outcomes on a global scale.
“At Sirio Pharma, our commitment to health extends beyond the products we manufacture; it’s about making a meaningful impact,” said Mark Dewis, General Manager of the Sirio Americas Business Unit.
“Partnering with Vitamin Angels allows us to extend that impact to vulnerable populations worldwide, helping to ensure that mothers and children have access to the vital nutrition they need to thrive, both globally and in our own communities.”
“We’re proud to partner with Sirio Pharma and deeply appreciate their generous support,” said Brittany Gunther, Director of Partnerships at Vitamin Angels.
“Together, we’re expanding access to life-changing nutrition for mothers and children at risk of malnutrition - helping communities around the world build stronger, healthier futures.”
